Pneumonia hospitalizations and mortality in children 3 – 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10)
| Autor: | Jalo Iliya, Denis R. Shatima, Beckie N. Tagbo, Adejumoke I. Ayede, Abieyuwa O. Fagbohun, Aliu Rasaq, Sarah Nalban, Isaac W. Elon, Ramatu Mohammed-Nafiu, Patience Ahmed, Oladapo B. Oyewole, Ayobami A. Bakare, Bidemi O. Yusuf, Olugbenga O. Akinrinoye, William N. Ogala, Adegoke G. Falade |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023) |
| Druh dokumentu: | article |
| ISSN: | 2164-5515 2164-554X 21645515 |
| DOI: | 10.1080/21645515.2022.2162289 |
| Popis: | Pneumococcal conjugate vaccine ten valent (PCV 10) was introduced into Nigeria in three phases. Phase 3 introduction started in August 2016. However, its impact on pneumonia admissions and mortality among vaccinated Nigerian children has not been determined. Data in the period before PCV-10 introduction (3 August 2013–2 August 2016), and after (3 August 2017–2 August 2020) were retrospectively extracted from the medical charts of eligible patients aged 3–24 months with hospitalized radiological pneumonia at the University College Hospital (UCH), Ibadan; National Hospital (NH), Abuja; and Federal Teaching Hospital (FTH), Gombe, allowing for an intervening period of 1 year. Proportions of the patients with hospitalized pneumonia and case fatality rates were determined during both periods. The results were compared using z-test, multiple logistic regression analysis and p |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|